Earnings Call · Q2 FY2023·2023-08-08

Q2 23EPS 0.00%·Rev n/aQ1 23EPS 0.00%·Rev n/aQ4 22EPS +8.70%·Rev n/aQ3 22EPS -100.00%*·Rev n/a⚠ consensus missing

Corvus Pharmaceuticals, Inc. CRVS

Zack Kubow — Host/Moderator

Leiv Lea — Chief Financial Officer

Richard Miller — Chief Executive Officer

+7.9%1d on move date+8.6% vs SPY3d+4.7%5d+0.9%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CRVS calls or request research access.

More CRVS calls Browse calls Request research access